Copyright
©The Author(s) 2023.
World J Hepatol. Jun 27, 2023; 15(6): 813-825
Published online Jun 27, 2023. doi: 10.4254/wjh.v15.i6.813
Published online Jun 27, 2023. doi: 10.4254/wjh.v15.i6.813
Mortality outcome, ALT level | No. of death, n (%) | Unadjusted | Age-adjusted | Multivariate-adjusted | |||
HR (95%CI) | P value | HR (95%CI) | P value | HR (95%CI) | P value | ||
All-cause | |||||||
< 0.5 ULN | 144 (34.0) | 1 | 1 | 1 | |||
0.5-1 ULN | 440 (38.8) | 1.16 (0.96-1.40) | 0.127 | 0.88 (0.73-1.06) | 0.176 | 0.91 (0.74-1.10) | 0.348 |
1-2 ULN | 187 (36.0) | 1.05 (0.85-1.31) | 0.632 | 0.83 (0.67-1.03) | 0.095 | 0.76 (0.60-0.97) | 0.027 |
≥ 2 ULN | 46 (30.7) | 0.89 (0.64-1.24) | 0.484 | 1.10 (0.79-1.53) | 0.585 | 0.82 (0.52-1.31) | 0.416 |
Cardiovascular disease | |||||||
< 0.5 ULN | 41 (9.7) | 1 | 1 | 1 | |||
0.5-1 ULN | 119 (10.5) | 1.10 (0.77-1.58) | 0.594 | 0.82 (0.58-1.17) | 0.282 | 0.86 (0.59-1.26) | 0.44 |
1-2 ULN | 442 (8.1) | 0.83 (0.54-1.28) | 0.41 | 0.65 (0.42-1.00) | 0.051 | 0.62 (0.38-1.02) | 0.061 |
≥ 2 ULN | 99 (6.0) | 0.61 (0.30-1.26) | 0.182 | 0.78 (0.38-1.61) | 0.504 | 0.85 (0.29-2.43) | 0.756 |
Cancer | |||||||
< 0.5 ULN | 31 (7.3) | 1 | 1 | 1 | |||
0.5-1 ULN | 97 (8.6) | 1.18 (0.79-1.77) | 0.425 | 0.93 (0.62-1.40) | 0.728 | 1.02 (0.66-1.57) | 934 |
1-2 ULN | 37 (7.1) | 0.96 (0.60-1.55) | 0.877 | 0.76 (0.47-1.23) | 0.261 | 0.83 (0.49-1.44) | 0.482 |
≥ 2 ULN | 15 (10.0) | 1.34 (0.72-2.48) | 0.352 | 1.38 (0.74-2.57) | 0.309 | 1.49 (0.61-3.68) | 0.395 |
Others | |||||||
< 0.5 ULN | 71 (49.7) | 1 | 1 | 1 | |||
0.5-1 ULN | 224 (50.9) | 0.91 (0.70-1.20) | 0.526 | 0.92 (0.71-1.20) | 0.549 | 0.89 (0.67-1.18) | 0.411 |
1-2 ULN | 108 (57.8) | 1.01 (0.75-1.37) | 0.935 | 1.08 (0.80-1.46) | 0.627 | 0.85 (0.61-1.20) | 0.366 |
≥ 2 ULN | 22 (47.8) | 0.99 (0.62-1.61) | 0.978 | 1.16 (0.72-1.88) | 0.548 | 0.62 (0.30-1.29) | 0.199 |
- Citation: Zheng JR, Wang ZL, Jiang SZ, Chen HS, Feng B. Lower alanine aminotransferase levels are associated with increased all-cause and cardiovascular mortality in nonalcoholic fatty liver patients. World J Hepatol 2023; 15(6): 813-825
- URL: https://www.wjgnet.com/1948-5182/full/v15/i6/813.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i6.813